A $210 million, 4-year program of "disease team grants," to be awarded this year, is the centerpiece of this thrust [toward support for translational research]. The program will entail perhaps 10 large grants to teams combining academic and industrial researchers working on a specific stem cell product for, say, Parkinson's disease. .....Found via: Science Magazine on the State of CIRM, David Jensen, California Stem cell Report, March 27, 2009.
Sunday, March 29, 2009
On a shift in focus for CIRM
CIRM Close-Hauled, Seeks Bonds to Sustain Headway by Constance Holden, Science 2009(Mar 27); 323(5922): 1660-1 [PubMed Citation]. Excerpt: